Abstract

Background Oral squamous cell carcinoma (OSCC) is a relatively common epithelial malignancy, and thus represents a significant public health problem. Early detection improves quality of life for affected patients. Identification of molecular markers (or biomarkers) which can predict disease progression is necessary for better management of these disorders. A correlation of cholinesterase with tumourigenesis, cell proliferation and cell differentiation has been observed. Butyrylcholinesterase (BChE; pseudocholinesterase) has been shown to be a biochemical marker for cervical cancer which is also an epithelial malignancy. In this study, we sought to estimate and compare serum BChE levels in healthy controls and patients with biopsy-proven oral squamous cell cancer (also an epithelial malignancy) before definitive therapy as radiotherapy or chemotherapy may alter the levels of BChE and may act as a confounding variable. Method After obtaining consent from biopsy proven oral cancer patients (n= 39) (before onset of any definitive treatment), and from age- and sex-matched healthy controls (n = 20), 2ml of blood was collected. After clot formation samples were centrifuged, serum was collected for estimation of BChE. Results Pre-treatment serum BChE levels were significantly elevated (p < 0.0001) in oral cancer patients compared to that of controls. BChE levels showed a significant increase (p = 0.005) with advancing stage in oral cancer patients. Conclusion Our results show there could be a role for serum BChE in determining the prognosis of oral cancer.

Original languageEnglish
Pages (from-to)374-378
Number of pages5
JournalAustralasian Medical Journal
Volume4
Issue number7
DOIs
Publication statusPublished - 2011

Fingerprint

Butyrylcholinesterase
Mouth Neoplasms
Serum
Biomarkers
Pseudocholinesterase
Biopsy
Squamous Cell Neoplasms
Neoplasms
Confounding Factors (Epidemiology)
Cholinesterases
Uterine Cervical Neoplasms
Disease Progression
Cell Differentiation
Squamous Cell Carcinoma
Radiotherapy
Therapeutics
Public Health
Quality of Life
Cell Proliferation
Drug Therapy

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{26e8900f7c1c4289b3193704782c1025,
title = "Significance of serum butyrylcholinesterase levels in oral cancer",
abstract = "Background Oral squamous cell carcinoma (OSCC) is a relatively common epithelial malignancy, and thus represents a significant public health problem. Early detection improves quality of life for affected patients. Identification of molecular markers (or biomarkers) which can predict disease progression is necessary for better management of these disorders. A correlation of cholinesterase with tumourigenesis, cell proliferation and cell differentiation has been observed. Butyrylcholinesterase (BChE; pseudocholinesterase) has been shown to be a biochemical marker for cervical cancer which is also an epithelial malignancy. In this study, we sought to estimate and compare serum BChE levels in healthy controls and patients with biopsy-proven oral squamous cell cancer (also an epithelial malignancy) before definitive therapy as radiotherapy or chemotherapy may alter the levels of BChE and may act as a confounding variable. Method After obtaining consent from biopsy proven oral cancer patients (n= 39) (before onset of any definitive treatment), and from age- and sex-matched healthy controls (n = 20), 2ml of blood was collected. After clot formation samples were centrifuged, serum was collected for estimation of BChE. Results Pre-treatment serum BChE levels were significantly elevated (p < 0.0001) in oral cancer patients compared to that of controls. BChE levels showed a significant increase (p = 0.005) with advancing stage in oral cancer patients. Conclusion Our results show there could be a role for serum BChE in determining the prognosis of oral cancer.",
author = "K. Prabhu and D. Naik and S. Ray and Vadiraj and A. Rao and A. Kamath",
year = "2011",
doi = "10.4066/AMJ.2011.569",
language = "English",
volume = "4",
pages = "374--378",
journal = "Australasian Medical Journal",
issn = "1836-1935",
publisher = "The Australasian Medical Journal Pty. Ltd.",
number = "7",

}

Significance of serum butyrylcholinesterase levels in oral cancer. / Prabhu, K.; Naik, D.; Ray, S.; Vadiraj; Rao, A.; Kamath, A.

In: Australasian Medical Journal, Vol. 4, No. 7, 2011, p. 374-378.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Significance of serum butyrylcholinesterase levels in oral cancer

AU - Prabhu, K.

AU - Naik, D.

AU - Ray, S.

AU - Vadiraj,

AU - Rao, A.

AU - Kamath, A.

PY - 2011

Y1 - 2011

N2 - Background Oral squamous cell carcinoma (OSCC) is a relatively common epithelial malignancy, and thus represents a significant public health problem. Early detection improves quality of life for affected patients. Identification of molecular markers (or biomarkers) which can predict disease progression is necessary for better management of these disorders. A correlation of cholinesterase with tumourigenesis, cell proliferation and cell differentiation has been observed. Butyrylcholinesterase (BChE; pseudocholinesterase) has been shown to be a biochemical marker for cervical cancer which is also an epithelial malignancy. In this study, we sought to estimate and compare serum BChE levels in healthy controls and patients with biopsy-proven oral squamous cell cancer (also an epithelial malignancy) before definitive therapy as radiotherapy or chemotherapy may alter the levels of BChE and may act as a confounding variable. Method After obtaining consent from biopsy proven oral cancer patients (n= 39) (before onset of any definitive treatment), and from age- and sex-matched healthy controls (n = 20), 2ml of blood was collected. After clot formation samples were centrifuged, serum was collected for estimation of BChE. Results Pre-treatment serum BChE levels were significantly elevated (p < 0.0001) in oral cancer patients compared to that of controls. BChE levels showed a significant increase (p = 0.005) with advancing stage in oral cancer patients. Conclusion Our results show there could be a role for serum BChE in determining the prognosis of oral cancer.

AB - Background Oral squamous cell carcinoma (OSCC) is a relatively common epithelial malignancy, and thus represents a significant public health problem. Early detection improves quality of life for affected patients. Identification of molecular markers (or biomarkers) which can predict disease progression is necessary for better management of these disorders. A correlation of cholinesterase with tumourigenesis, cell proliferation and cell differentiation has been observed. Butyrylcholinesterase (BChE; pseudocholinesterase) has been shown to be a biochemical marker for cervical cancer which is also an epithelial malignancy. In this study, we sought to estimate and compare serum BChE levels in healthy controls and patients with biopsy-proven oral squamous cell cancer (also an epithelial malignancy) before definitive therapy as radiotherapy or chemotherapy may alter the levels of BChE and may act as a confounding variable. Method After obtaining consent from biopsy proven oral cancer patients (n= 39) (before onset of any definitive treatment), and from age- and sex-matched healthy controls (n = 20), 2ml of blood was collected. After clot formation samples were centrifuged, serum was collected for estimation of BChE. Results Pre-treatment serum BChE levels were significantly elevated (p < 0.0001) in oral cancer patients compared to that of controls. BChE levels showed a significant increase (p = 0.005) with advancing stage in oral cancer patients. Conclusion Our results show there could be a role for serum BChE in determining the prognosis of oral cancer.

UR - http://www.scopus.com/inward/record.url?scp=79961074070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79961074070&partnerID=8YFLogxK

U2 - 10.4066/AMJ.2011.569

DO - 10.4066/AMJ.2011.569

M3 - Article

VL - 4

SP - 374

EP - 378

JO - Australasian Medical Journal

JF - Australasian Medical Journal

SN - 1836-1935

IS - 7

ER -